Transcranial Sonography in Movement Disorders

Transcranial sonography (TCS) is a non-invasive ultrasonographic technique that employs low-frequency acoustic waves through the temporal bone window to visualise deep brain structures. In movement disorders, its principal application lies in imaging the substantia nigra, where increased echogenicity often reflects iron accumulation and glial changes. This modality has gained traction as an adjunct to clinical examination, offering real-time assessment of midbrain anatomy without ionising radiation or contrast agents. TCS facilitates early detection of Parkinsonian syndromes, aids differentiation from essential tremor and atypical parkinsonian disorders, and supports monitoring of disease progression. Quantitative measures such as the area of nigral hyperechogenicity and third ventricular width have emerged as promising biomarkers for cognitive decline and motor severity. While operator dependency and inadequate bone windows can limit its utility, standardised protocols and advances in image analysis—particularly machine-learning-based segmentation—are enhancing reproducibility. Globally, TCS is valued for its accessibility in outpatient clinics and its potential to inform therapeutic decision-making in resource-limited settings.

Research from Nature Portfolio

A comprehensive meta-analysis consolidated data from over thirty studies involving more than 4,000 participants to evaluate the diagnostic performance of substantia nigra sonography in Parkinson’s disease. Pooled sensitivity reached approximately 83 % and specificity 87 %, with a diagnostic odds ratio near 43, confirming that nigral hyperechogenicity is a robust marker for idiopathic Parkinson’s disease versus healthy controls. Meta-regression highlighted heterogeneity arising from operator experience and imaging parameters, underscoring the need for harmonised acquisition and measurement criteria. This work remains a foundational reference, demonstrating that TCS can reliably distinguish Parkinsonian subjects at early disease stages and informing subsequent efforts to integrate ultrasound biomarkers into clinical guidelines.

Transcranial Sonography in Movement Disorders publication trend

The graph below shows the total number of articles in transcranial sonography in movement disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Echogenicity: The capacity of tissue to reflect ultrasound waves, with elevated signals indicating changes such as iron deposition or gliosis.

Substantia Nigra: A midbrain nucleus critical for motor control, whose altered echotexture is characteristic of Parkinsonian disorders.

Hyperechogenicity: Regions of increased brightness on ultrasound images, typically denoting higher acoustic reflectivity due to iron accumulation.

Quantitative Susceptibility Mapping: An MRI-based technique that quantifies magnetic susceptibility differences to estimate regional brain iron content.

Dual-Channel Network: A deep-learning framework that simultaneously analyses paired ultrasound inputs to improve classification performance.

Third Ventricular Width: A linear measurement between the lateral walls of the third ventricle, used as an indicator of cerebral atrophy or enlargement.

References

1. Third ventricular width by transcranial sonography is associated with cognitive impairment in Parkinson's disease. CNS Neuroscience & Therapeutics (2023).
2. Segmentation of Substantia Nigra in Brain Parenchyma Sonographic Images Using Deep Learning. Journal of Imaging (2023).
3. Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson’s disease: A Systematic Review and Meta-analysis. Scientific Reports (2016).
4. Systematic review-based guideline “Parkinson’s disease” of the German Society of Neurology: diagnostic use of transcranial sonography. Journal of Neurology (2024).
5. High correlation of quantitative susceptibility mapping and echo intensity measurements of nigral iron overload in Parkinson’s disease. Journal of Neural Transmission (2024).
6. Automatic Transcranial Sonography-Based Classification of Parkinson’s Disease Using a Novel Dual-Channel CNXV2-DANet. Bioengineering (2024).